ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Protagonist Therapeutics Inc

Protagonist Therapeutics Inc (PTGX)

45.80
-0.48
(-1.04%)
Closed 22 April 6:00AM
45.80
0.00
( 0.00% )
Pre Market: 6:12PM

Income Statement

Balance Sheet

Cash Flow

Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 00060M254.95M4.17M4.68M170.64M
Operating Income -36.02M-42.35M-38.33M23.05M206.31M-38.79M-41.45M126.78M
Pre Tax Income -33.73M-38.46M-34.11M27.34M210.67M-31.29M-33.63M133.66M
Net Income -33.73M-38.46M-34.11M27.34M207.34M-30.62M-33.21M131.67M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -36.22M-42.37M-38.36M23.09M206.29M-38.7M-41.31M126.81M
EBITDA -35.77M-42.12M-38.08M23.3M206.55M-38.55M-41.22M126.97M
Year End 31 December 2024 20172018201920202021202220232024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 20.06M30.93M231k28.63M27.36M26.58M60M434.43M
Operating Income -37.9M-42.27M-80.52M-64.52M-125.85M-131.37M-93.65M252.84M
Pre Tax Income -36.96M-39.72M-77.88M-64.85M-125.55M-127.39M-78.96M279.41M
Net Income -36.96M-38.92M-77.19M-66.15M-125.55M-127.39M-78.96M275.19M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -1.753-1.679-2.836-1.512-2.625-2.582-1.3694.617
EBIT -37.9M-42.27M-80.52M-65.15M-125.99M-131.45M-93.85M253.09M
EBITDA -37.49M-41.74M-79.82M-63.73M-125.03M-130.34M-92.68M253.74M